Ignite Creation Date:
2024-05-06 @ 7:30 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06030011
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2023-09-01
Brief Title:
Implementing the NYU Electronic Patient Visit Assessment ePVA for Head and Neck Cancer In Rural and Urban Populations
Sponsor:
The University of Texas Health Science Center Houston
Organization:
The University of Texas Health Science Center Houston
Study Overview
Official Title:
Implementing the NYU Electronic Patient Visit Assessment ePVA for Head and Neck Cancer In Rural and Urban Populations
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The PI and the research team developed the New York University NYU Electronic Patient Visit Assessment ePVA for head and neck cancer HNC as a patient-reported outcome measure PRO for the early detection of uncontrolled symptoms The ePVA is digital patient-reported symptom monitoring system providing actionable information at point-of-care that enables clinicians to provide real-time interventions The study aims to advance the science of cancer care delivery by testing the effectiveness of the ePVA as a digital patient-reported monitoring system for patients with HNC in real-world settings and identify implementation strategies that optimize the effectiveness of the ePVA in diverse rural and urban settings The study hypothesis is that participants assigned to the ePVA arm will have better swallowing taste and smell and social function than participants assigned to usual care arm at 4 weeks after completing radiation therapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None